http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201600242-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
| filingDate | 2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201600242-A1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET AND METHOD FOR ITS PREPARATION |
| abstract | The invention relates to the field of medicine, pharmaceutical industry and relates to agents with nootropic and neuromodulatory activity. Pharmaceutical composition in the form of a tablet, possessing nootropic and neuromodulatory activity, characterized in that it includes N-carbamoylmethyl-4-phenyl-2-pyrrolidone as an active principle, lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, silicon dioxide as excipients colloid (aerosil) and calcium stearate. Tablets composition obtained by direct compression. The resulting preparation has a lower variability of pharmacological action. |
| priorityDate | 2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.